ICER's mission is to lead innovation in comparative effectiveness research through methods that integrate considerations of clinical benefit and economic value. Through a unique collaboration with patients, clinicians, manufacturers, insurers and other healthcare stakeholders, ICER develops tools to support patient decisions and medical policy that share the goal of achieving maximum value for every healthcare dollar.
| Brachytherapy and proton beam therapy appraisal now available, Dec 2008 |
|
The final appraisal document, "Brachytherapy and Proton Beam Therapy for Treatment of Clinically Localized, Low-Risk Prostate Cancer " is now available on the ICER website.
|